AtheroNova
1 SlideShare
Personal Information
Entreprise/Lieu de travail
Irvine, CA United States
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.atheronova.com/home.html
À propos
AtheroNova, through its wholly-owned subsidiary, AtheroNova Operations, is a development stage company currently researching novel patents-pending applications of certain natural compounds to regress atherosclerotic plaque deposits, a process called delipidization. The Company is currently conducting two additional animal studies to validate the findings of its initial study and prepare for human trials. AtheroNova plans to develop multiple applications for its compounds, to be used in pharmaceutical grade products, for the treatment of atherosclerosis.
Mots-clés
prime equity research per ahro atheronova
Tout plus

Documents

(1)

OTCBB: AHRO - Initiation of Coverage Dec. 7 2011

il y a 12 ans • 332 Vues
Personal Information
Entreprise/Lieu de travail
Irvine, CA United States
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.atheronova.com/home.html
À propos
AtheroNova, through its wholly-owned subsidiary, AtheroNova Operations, is a development stage company currently researching novel patents-pending applications of certain natural compounds to regress atherosclerotic plaque deposits, a process called delipidization. The Company is currently conducting two additional animal studies to validate the findings of its initial study and prepare for human trials. AtheroNova plans to develop multiple applications for its compounds, to be used in pharmaceutical grade products, for the treatment of atherosclerosis.
Mots-clés
prime equity research per ahro atheronova
Tout plus